Immunology

Utilizing the funding from BIPP, Tergene Biotech initiated a project to develop an indigenous vaccine to tackle pneumonia that kills more children under the age of five than any other disease

Pneumonia kills an estimated 1.6 million children under the age of five globally, every year, according to statistics available with the World Health Organization.

Full story »

Multiple inhibitory molecules create a profoundly immunuosuppressive environment during chronic viral infections in humans and mice. Therefore, eliciting effective immunity in this context represents a challenge. Here, we report that

Full story »

Prolonged alcohol consumption is a significant co-factor in the progression of chronic viral infections including hepatitis C and HIV, which are both single-stranded RNA viruses. Toll like receptor 8 (TLR8), a pattern recognition receptor expressed in monocytes, senses viral single stranded RNA as a danger signal

Full story »

A new treatment could revolutionize the treatment of patients after a heart attack. Hendrik Jan Ankersmit from the Medical University of Vienna has developed a protein solution

Full story »

Human immunodeficiency virus (HIV) could be reduced to a “minor chronic infection” akin to herpes, Spanish scientists developing a new vaccine have claimed.

Could HIV one day be treated as nothing more than a ‘minor chronic infection?’ That’s what researchers at the National Biotech Center in Madrid, Spain are hoping to eventually achieve with MVA-B, their early-stage HIV vaccine.

Full story »